European Medicines Agency endorses use of dexamethasone in COVID-19 patients on oxygen or mechanical ventilation, EMA
Based on a review of RECOVERY trial, dexamethasone is recommended as an option in adults and adolescents (>12 years;> 40 kg) who require supplemental oxygen therapy. The recommended dose, administered orally or by injection/infusion is 6 milligrams once a day for up to 10 days. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - September 22, 2020 Category: Consumer Health News Source Type: news

EMA Backs Dexamethasone for Severe COVID-19 After Data Review EMA Backs Dexamethasone for Severe COVID-19 After Data Review
Dexamethasone can be considered a treatment option for adults and adolescents with SARS-CoV-2 infection who require supplemental oxygen therapy.International Approvals (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - September 19, 2020 Category: Infectious Diseases Tags: Infectious Diseases News Alert Source Type: news

Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19 A Meta-analysis
Importance Effective therapies for patients with coronavirus disease 2019 (COVID-19) are needed, and clinical trial data have demonstrated that low-dose dexamethasone reduced mortality in hospitalized patients with COVID-19 who required respiratory support. Objective To estimate the association between administration of corticosteroids compared with usual care or placebo and 28-day all-cause mortality. Design, Setting, and Participants Prospective meta-analysis that pooled data from 7 randomized clinical trials that evaluated the efficacy of corticosteroids in 1703 critically ill patients with COVID-19. The trials were con...
Source: Current Awareness Service for Health (CASH) - September 17, 2020 Category: Consumer Health News Source Type: news

Lilly ’s Barcitinib For Covid-19 – Too Little, Too Late?
Unless Lilly can show more impressive data for barcitinib combinations, such as in a study of barcitinib/remdesivir vs. dexamethasone/remdesivir, an EUA seems premature. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 16, 2020 Category: Pharmaceuticals Authors: John LaMattina, Contributor Tags: Healthcare /healthcare Innovation /innovation Coronavirus business pharma Source Type: news

Hemady (Dexamethasone Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 14, 2020 Category: Drugs & Pharmacology Source Type: news

How the Aging Immune System Makes Older People Vulnerable to Covid-19
As we age, the immune system begins to shift into a heightened state of alert, dialing up inflammation and running out of certain immune cells. (Source: NYT Health)
Source: NYT Health - September 8, 2020 Category: Consumer Health News Authors: Veronique Greenwood Tags: Coronavirus (2019-nCoV) Coronavirus Risks and Safety Concerns Dexamethasone (Drug) Immune System Age, Chronological Elderly Research Vaccination and Immunization your-feed-science Source Type: news

Study says cheap steroid reduces COVID-19 mortality by 33%
(Natural News) Some interesting news has emerged about a possible remedy for the Wuhan coronavirus (COVID-19) that, just like hydroxychloroquine (HCQ), is inexpensive and already widely available. A study published in the Journal of the American Medical Association found that the commonly used steroid drugs dexamethasone, hydrocortisone and methylprednisolone can help to reduce the mortality... (Source: NaturalNews.com)
Source: NaturalNews.com - September 6, 2020 Category: Consumer Health News Source Type: news

Steroid Drugs Are an Effective Treatment for Severe COVID-19: WHO
A meta-analysis of seven randomized controlled trials concludes that dexamethasone and other corticosteroids reduce 28-day mortality in seriously ill patients. (Source: The Scientist)
Source: The Scientist - September 3, 2020 Category: Science Tags: News & Opinion Source Type: news

Two types of steroid found to save lives of some Covid-19 patients
Analysis of seven trials finds dexamethasone and hydrocortisone should be given in severe casesCoronavirus – latest updatesSee all our coronavirus coverageStudies around the world have confirmed that steroids can save lives in the Covid-19 pandemic, leading to new recommendations from the World Heath Organization that doctors should give them to severely ill patients.In June, the Recovery trial run in most NHS hospitals and led by Oxford University found that the lives of one in eight people sick enough from Covid-19 to need a ventilator could be saved by a steroid called dexamethasone.Continue reading... (Source: Gu...
Source: Guardian Unlimited Science - September 3, 2020 Category: Science Authors: Sarah Boseley Health editor Tags: Medical research Coronavirus outbreak Science World news Source Type: news

Inexpensive Steroids Can Save Lives Of Seriously Ill COVID-19 Patients
Multiple studies now confirm earlier research: Dexamethasone and hydrocortisone, drugs that reduce an immune system's overreaction, can help reduce deaths of hospitalized COVID-19 patients.(Image credit: Photo Illustration by Soumyabrata Roy/NurPhoto via Getty Images) (Source: NPR Health and Science)
Source: NPR Health and Science - September 2, 2020 Category: Consumer Health News Authors: Richard Harris Source Type: news

Scientists Report Steroids Can Be Lifesaving for Covid-19 Patients
New data in hand, the W.H.O. recommended that doctors give the drugs to critically ill patients worldwide. (Source: NYT Health)
Source: NYT Health - September 2, 2020 Category: Consumer Health News Authors: Roni Caryn Rabin Tags: your-feed-science Dexamethasone (Drug) Remdesivir (Drug) Coronavirus (2019-nCoV) Steroids Immune System JAMA (Journal of American Medical Assn) Vanderbilt University World Health Organization Source Type: news

Steroids Can Be Lifesaving for Covid-19 Patients, Scientists Report
New data in hand, the W.H.O. recommended that doctors give the drugs to critically ill patients worldwide. (Source: NYT Health)
Source: NYT Health - September 2, 2020 Category: Consumer Health News Authors: Roni Caryn Rabin Tags: your-feed-science Dexamethasone (Drug) Remdesivir (Drug) Coronavirus (2019-nCoV) Steroids Immune System JAMA (Journal of American Medical Assn) Vanderbilt University World Health Organization Source Type: news

Dexamethasone, other corticosteroids help hospitalized COVID-19 patients, research finds
The corticosteroid dexamethasone reduces the need for ventilator support in patients hospitalized with COVID-19, according to a study published Wednesday by JAMA. (Source: Health News - UPI.com)
Source: Health News - UPI.com - September 2, 2020 Category: Consumer Health News Source Type: news

WHO recommends cheap everyday steroids as Covid-19 treatment
Dexamethasone and hydrocortisone offer hope in curbing death toll (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - September 2, 2020 Category: Pharmaceuticals Source Type: news

Severely ill COVID-19 patients may benefit from glucocorticoid drug
Dexamethasone reduces dangerous inflammation seen late in the disease, say an NIEHS scientist and his collaborator. (read more) (Source: Environmental Factor - NIEHS Newsletter)
Source: Environmental Factor - NIEHS Newsletter - September 2, 2020 Category: Environmental Health Source Type: news

Effect of dexamethasone on days alive, ventilator-free in patients with COVID-19, acute respiratory distress syndrome
(JAMA Network) This randomized clinical trial in Brazil of 299 patients with COVID-19 and moderate or severe acute respiratory distress syndrome (ARDS) examined if   intravenous dexamethasone plus standard care compared with standard care alone would increase the number of days patients were alive and free from mechanical ventilation. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 2, 2020 Category: Infectious Diseases Source Type: news

Why do Covid fatalities seem steady when infection numbers are rising?
While some scientists believe the virus has become less deadly, others look at the factors that suggest otherwiseAre Covid-19 death rates decreasing?Most statistics indicate that although cases of Covid-19 are rising in many parts of Europe and the United States, the number of deaths and cases of severe complications remain relatively low. For example, patients on ventilators have dropped from 3,000 at the epidemic ’s peak in Britain to 70. At the same time, the number of cases in the UK have begun to rise in many areas.What lies behind this trend?Doctors are unsure exactly what is going on. Some suggest that medical...
Source: Guardian Unlimited Science - August 25, 2020 Category: Science Authors: Robin McKie Tags: Coronavirus outbreak Infectious diseases Medical research Microbiology Science World news UK news US news Source Type: news

Why do Covid fatalities remain low when infection numbers are rising?
While some scientists believe the virus has become less deadly, others look at the factors that suggest otherwiseAre Covid-19 death rates decreasing?Most statistics indicate that although cases of Covid-19 are rising in many parts of Europe and the United States, the number of deaths and cases of severe complications remain relatively low. For example, patients on ventilators have dropped from 3,000 at the epidemic ’s peak in Britain to 70. At the same time, the number of cases in the UK have begun to rise in many areas.Why lies behind this trend?Doctors are unsure exactly what is going on. Some suggest that medical ...
Source: Guardian Unlimited Science - August 23, 2020 Category: Science Authors: Robin McKie Tags: Coronavirus outbreak Infectious diseases Science Medical research Microbiology World news UK news US news Source Type: news

FDA approves carfilzomib and daratumumab with dexamethasone for multiple myeloma
On August 20, 2020, the Food and Drug Administration approved carfilzomib (KYPROLIS, Onyx Pharmaceuticals, Inc.) and daratumumab (DARZALEX, Janssen Biotech, Inc.) in combination with dexamethasone for adult patients with relapsed or refractory multiple myeloma who have received one to three lines o (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - August 21, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA Approves New Kyprolis (carfilzomib) Combination Regimen with Darzalex (daratumumab) and Dexamethasone in Both Once- And Twice-Weekly Dosing Regimens
THOUSAND OAKS, Calif., Aug. 20, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the U.S. Food and Drug Administration (FDA) has approved the expansion of the Kyprolis (carfilzomib) U.S. prescribing information to include its use in... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 20, 2020 Category: Drugs & Pharmacology Source Type: news

Remdesivir Tests for Covid Treatments Enter New Phase
A clinical trial showed that remdesivir helped hospitalized patients. Now researchers are asking whether when the drug is paired with another antiviral drug, patients will recover faster. (Source: NYT Health)
Source: NYT Health - August 18, 2020 Category: Consumer Health News Authors: Gina Kolata Tags: Remdesivir (Drug) Tests (Medical) Research Placebos Dexamethasone (Drug) Coronavirus (2019-nCoV) Interferon Beta (Drugs) Immune System Gilead Sciences Inc National Institute of Allergy and Infectious Diseases your-feed-healthcare Pet Source Type: news

RVD Induction Therapy in Newly Diagnosed Multiple Myeloma RVD Induction Therapy in Newly Diagnosed Multiple Myeloma
What benefits might be achieved with a combination lenalidomide, bortezomib, and dexamethasone induction regimen in patients with multiple myeloma?Journal of Clinical Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 17, 2020 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Guidance Covers Glycemia in Dexamethasone-Treated COVID-19 Guidance Covers Glycemia in Dexamethasone-Treated COVID-19
The latest document from the COVID-19 response group of the Association of British Clinical Diabetologists is a response to the recent RECOVERY trial.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - August 7, 2020 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

Scientists Uncover Biological Signatures of the Worst Covid-19 Cases
Studies of patients with severe cases of Covid-19 show the immune system lacks its usual coordinated response. (Source: NYT Health)
Source: NYT Health - August 4, 2020 Category: Consumer Health News Authors: Katherine J. Wu Tags: Immune System Coronavirus (2019-nCoV) Science (Journal) Nature Medicine (Journal) Dexamethasone (Drug) Viruses Microbiology Research your-feed-science your-feed-health Source Type: news

What We Don ’t Know About COVID-19 Can Hurt Us
Countries around the world have introduced stringent control measures to stop COVID-19 outbreaks growing, but now many find themselves facing the same situation again. From Melbourne to Miami, the relaxation of measures had led to increasing flare-ups, which in some places has already meant reclosing schools, businesses or travel routes. Within the U.S. and among different countries, places with wildly varying public-health policies have experienced wildly diverse outcomes. Most ominously, infections are rising rapidly in many places where they once were falling. So how do countries avoid an indefinite, unsustainable, cycl...
Source: TIME: Health - August 3, 2020 Category: Consumer Health News Authors: Adam Kucharski Tags: Uncategorized COVID-19 Source Type: news

CRP Test Pinpoints Which COVID Patients Should Get Steroids CRP Test Pinpoints Which COVID Patients Should Get Steroids
Dexamethasone and other steroids helped some hospitalized with COVID-19 but were potentially harmful when inflammation was low; a C-reactive protein test may identify those most likely to benefit.Medscape Medical News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - July 24, 2020 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news

Steroids Other Than Dexamethasone May Also Help Battle COVID-19
THURSDAY, July 23, 2020 -- The steroid medication dexamethasone has been proven to help people severely ill with COVID-19. Now a new study hints that other drugs in the same class may also work -- in the right patients. The findings are from a... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 23, 2020 Category: General Medicine Source Type: news

Coronavirus: Blood test shows if dexamethasone will help user
A study of hospitalised patients in New York showed those with high levels of inflammatory markers in their blood had a reduced chance of dying when treated with steroids like dexamethasone. (Source: the Mail online | Health)
Source: the Mail online | Health - July 22, 2020 Category: Consumer Health News Source Type: news

New CCC19 data offer insights on COVID treatments for people with cancer
(Vanderbilt University Medical Center) Newly released data on treatment outcomes of people with cancer diagnosed with COVID-19 reveal a racial disparity in access to Remdesivir, an antiviral drug that has been shown to shorten hospital stays, and increased mortality associated with dexamethasone, a steroid that has had the opposite effect in the general patient population. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 22, 2020 Category: Cancer & Oncology Source Type: news

COVID-19 Update: New Data on Vaccines, Dexamethasone Results COVID-19 Update: New Data on Vaccines, Dexamethasone Results
These are the coronavirus stories you need to know about today.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - July 21, 2020 Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news

New Data on Vaccines, Dexamethasone Results New Data on Vaccines, Dexamethasone Results
These are the coronavirus stories you need to know about today.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - July 21, 2020 Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news

28-Day Mortality in COVID-19 Lower With Dexamethasone
MONDAY, July 20, 2020 -- Dexamethasone lowers 28-day mortality in patients hospitalized with COVID-19 who are receiving invasive mechanical ventilation or oxygenation alone, according to a study published online July 17 in the New England Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 20, 2020 Category: Pharmaceuticals Source Type: news

A Cheap, Common Steroid Called Dexamethasone May Help Patients With Severe COVID-19, Study Says
A paper published Friday in the New England Journal of Medicine suggests a low-cost steroid may be a valuable treatment for severe COVID-19, building upon encouraging preliminary findings from last month. In June, U.K. researchers reported that dexamethasone—a cheap, widely available steroid that can lower inflammation in the body—appeared to reduce by a third the risk of death among patients with severe COVID-19. U.K. practitioners began using dexamethasone the very same day the results were announced, but some medical experts were more guarded, arguing no conclusions should be made without seeing the trial&rs...
Source: TIME: Health - July 17, 2020 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 Source Type: news

Coronavirus: Hydroxychloroquine trialled over better treatments
About 200 of 1,200 clinical trials looked at anti-malaria drug hydroxychloroquine as a potential treatment for coronavirus, but fewer than 25 studies examined dexamethasone or remdesivir. (Source: the Mail online | Health)
Source: the Mail online | Health - July 6, 2020 Category: Consumer Health News Source Type: news

Forget any false sense of security: we are still at the start of the global pandemic | Jeremy Farrar
Until every country is protected, we are all at risk. Only effective vaccines and treatments will allow us to eradicate coronavirus• Dr Jeremy Farrar is director of the Wellcome TrustSix months on from the first cases of Covid-19 emerging in Wuhan, many of us in Britain will be feeling a mixture of relief and trepidation as England ’slockdown eases. The loosening of restrictions, alongside warmer weather, has brought hope. The UK government is understandably anxious to get society and the economy back on track. This is what we all want, and it ’s what scientists are striving to ensure.Since the virus began...
Source: Guardian Unlimited Science - July 2, 2020 Category: Science Authors: Jeremy Farrar Tags: Coronavirus outbreak Medical research Infectious diseases Science World news Source Type: news

What Coronavirus Researchers Can Learn From Economists
Randomized controlled trials remain the gold standard, but natural experiments can help doctors who need answers now. (Source: NYT Health)
Source: NYT Health - June 30, 2020 Category: Consumer Health News Authors: Anupam B. Jena and Christopher M. Worsham Tags: Dexamethasone (Drug) Coronavirus (2019-nCoV) Economics (Theory and Philosophy) Doctors Research Source Type: news

Gilead ’s $2,340 Price for Coronavirus Drug Remdesivir Draws Criticism
The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries. Gilead Sciences announced the price Monday for remdesivir, and said the price would be $3,120 for patients with private insurance. The amount that patients pay out of pocket depends on insurance, income and other factors. “We’re in uncharted territory with pricing a new medicine, a novel medicine, in a pandemic,” Gilead’s chief executive, Dan O’Day, tol...
Source: TIME: Science - June 29, 2020 Category: Science Authors: MARILYNN MARCHIONE / AP Tags: Uncategorized COVID-19 News News Desk Source Type: news

Dexamethasone, CEBM
" If the full published data from the RECOVERY trial of dexamethasone in the treatment of hospitalized patients with COVID-19 confirm the results in the preliminary publications, the decision to adopt it in the NHS before publication of the final paper will have been justified. " (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 29, 2020 Category: Consumer Health News Source Type: news

Health Ministry adds steroid dexamethasone in COVID-19 treatment protocol
The updated protocol includes the advice to use dexamethasone as an alternative choice to methylprednisolone for managing moderate to severe cases of COVID-19. The change has been made after considering the latest available evidence and expert consultation, the ministry said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 27, 2020 Category: Pharmaceuticals Source Type: news

US Demand Outstripping Supply of Steroid Treatment for COVID US Demand Outstripping Supply of Steroid Treatment for COVID
Soaring hospital demand for the steroid dexamethasone, which British researchers say significantly reduces mortality among severely ill COVID-19 patients, is outstripping supply of the drug.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - June 26, 2020 Category: Intensive Care Tags: Infectious Diseases News Source Type: news

Coronavirus Social: Mixed Response to Dexamethasone Preprint Coronavirus Social: Mixed Response to Dexamethasone Preprint
Although many users praised the results of the Recovery trial now in preprint, others want more definitive answers.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - June 26, 2020 Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news

Steroid that helps severely ill coronavirus patients may be dangerous for milder cases
A study from the UK found that dexamethasone, a steroid found to help reduce death rates in severely ill coronavirus patients, was not beneficial in those with mild or early stage cases. (Source: the Mail online | Health)
Source: the Mail online | Health - June 26, 2020 Category: Consumer Health News Source Type: news

Breakthrough Drug for Covid-19 May Be Risky for Mild Cases
That study about dexamethasone has arrived with a big asterisk: While it appears to help severely ill patients, it harms others. (Source: NYT Health)
Source: NYT Health - June 25, 2020 Category: Consumer Health News Authors: Roni Caryn Rabin Tags: your-feed-science Coronavirus (2019-nCoV) Dexamethasone (Drug) Clinical Trials Immune System Drugs (Pharmaceuticals) Steroids Oxford University Source Type: news

US hospital orders soar for Covid-19 steroid treatment
Dexamethasone suppliers unable to keep up with demand, filling only 54 per cent of the orders (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - June 25, 2020 Category: Pharmaceuticals Source Type: news

Coronavirus live news: Saudi Arabia closes borders to hajj attendees as global Covid-19 cases pass 9m
Texas ‘wide open for business’;WHO urges dexamethasone steroid boom; South Africa infections top 100,000. Follow the latest updatesSaudi Arabia closes borders to hajj attendeesHalf of US states see spike as officials warn first wave far from overGlobal cases pass 9 millionBarcelona opera reopens with performance for nearly 3,000 potted plantsSee all our coronavirus coverage10.01amBSTPeople inFrance are being urged to go back to their places of work in a new easing of the coronavirus regulations following a “significant improvement in the health situation”.The employment minister, Muriel P éni...
Source: Guardian Unlimited Science - June 23, 2020 Category: Science Authors: Nick Ames (now); Helen Sullivan (earlier) Tags: Coronavirus outbreak World news Science Infectious diseases US news Australia news UK news Microbiology Medical research Brazil Source Type: news

Local Covid drug makers ramp up capacity
This follows companies successfully developing the formulations Favipiravir and Remdesivir, the drugs, which along with dexamethasone have been included in the Covid-19 clinical management protocol in Southeast Asia, Eastern Europe and Gulf Cooperation Council region. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 23, 2020 Category: Pharmaceuticals Source Type: news

Doctor Warns Of Risks In Rush To Embrace A COVID-19 Treatment
As researchers herald dexamethasone as a potential breakthrough treatment for critically ill patients, Dr. Kirsten Lyke says publicizing research that hasn't been rigorously vetted could erode trust.(Image credit: Simon Dawson/Bloomberg via Getty Images) (Source: NPR Health and Science)
Source: NPR Health and Science - June 20, 2020 Category: Consumer Health News Authors: Scott Simon Source Type: news

COVID-19 Update: Dexamethasone Use, Don't Forget the Fomites COVID-19 Update: Dexamethasone Use, Don't Forget the Fomites
These are the coronavirus stories you need to know about today.Medscape Medical News (Source: Medscape Emergency Medicine Headlines)
Source: Medscape Emergency Medicine Headlines - June 20, 2020 Category: Emergency Medicine Tags: Infectious Diseases News Source Type: news

Our knowledge of Covid-19 changes every day. Hindsight is misleading when it comes to science | Gideon Meyerowitz-Katz
It ’s tempting to look back and say ‘if only we had known’ – but that ignores the realitiesTheresults of a Covid-19 study have been announced. Unlike most of the previous results, this study seems immediately to be a game-changer – rather than minor benefits from an expensive drug, or spurious nonsense from a dubious trial, these results show that a cheap and common medication, dexamethasone, could reduce the risk of death in people with severe disease by a substantial amount. The study was large enough to be meaningful an d its finding likely to be true.This is, without qualification, fantast...
Source: Guardian Unlimited Science - June 19, 2020 Category: Science Authors: Gideon Meyerowitz-Katz Tags: Medical research Coronavirus outbreak Science Infectious diseases Health World Health Organization Epidemics Source Type: news

Dexamethasone for COVID-19: Some Hospitals Wait to Change Practice Dexamethasone for COVID-19: Some Hospitals Wait to Change Practice
Dexamethasone may be the first treatment shown to reduce mortality in COVID-19 patients. While some physicians were prescribing steroids already, others are still wary.Medscape Medical News (Source: Medscape Emergency Medicine Headlines)
Source: Medscape Emergency Medicine Headlines - June 19, 2020 Category: Emergency Medicine Tags: Infectious Diseases News Source Type: news